American Journal of Epidemiology Vol. 141, No. 8: 732-740
Copyright © 1995 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
Family History and Prostate Cancer Risk in Black, White, and Asian Men in the United States and Canada
1Department of Health Research and Policy, Stanford University School of Medicine Stanford, CA
2Department of Preventive Medicine, University of Southern California Los Angeles, CA
3Cancer Center of Hawaii, University of Hawaii at Manoa Honolulu, HI
4Division of Epidemiology, Biometry, and Occupational Oncology, British Columbia Cancer Agency Vancouver, British Columbia, Canada
5Epidemiology Unit, National Cancer Institute of Canada, University of Toronto Toronto, Ontario, Canada
6Norther California Cancer Center Union City, CA
7Department of Urology, Stanford University School of Medicine Stanford, CA
Reprint requests to Dr. Alice S. Whittemore, Department of Health Research and Policy, Redwood Building, Room T2O4, Stanford University School of Medicine, Stanford, CA 94305-50
Increased risk of prostate cancer in men with a family history of the disease has been observed consistently in epidemiologic studies. However, most studies have been confined to white men; little is known about familial aggregation of prostate cancer in populations with unusually high incidence, such as African Americans, or in populations with low incidence, such as Asian-Americans. The authors report results from a population-based case-control study of prostate cancer among blacks, whites, and Asian-Americans in the United States and Canada. Controls were matched to cases on age (5-year groups), ethnicity (black, white, Chinese-American, Japanese-American), and region of residence (Los Angeles, San Francisco, Hawaii, Vancouver, Toronto). In the combined group of participants, 5% of controls and 13% of cases reported a father, brother, or son with prostate cancer. These prevalences were somewhat lower among Asian-Americans than among blacks or whites. A positive family history was associated with a statistically significant two- to threefold increase in risk in each of the three ethnic groups. The overall odds ratio associated with such a family history, adjusted for age and ethnicity, was 2.5 (95% confidence interval 1.9–3.3). This odds ratio varied by neither ethnicity nor age of the participants. Sera from 1,087 controls were used to examine the relations between family history and serum concentrations of androgens and prostate-specific antigen. The concentrations of sex hormone-binding globulin were slightly higher in men with than without a positive family history. Prostate-specific antigen concentrations were unrelated to family history. Am J Epidemiol 1995;141:732–40.
androgens;; Asian-Americans;; blacks;; ethnic groups;; family;; prostatic neoplasms;; whites.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. G. Skinner and G. G. Schwartz Serum Calcium and Incident and Fatal Prostate Cancer in the National Health and Nutrition Examination Survey Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2302 - 2305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Nagata, T. Sonoda, M. Mori, N. Miyanaga, K. Okumura, K. Goto, S. Naito, K. Fujimoto, Y. Hirao, A. Takahashi, et al. Dietary Isoflavones May Protect against Prostate Cancer in Japanese Men J. Nutr., August 1, 2007; 137(8): 1974 - 1979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Bloom, S. L. Stewart, I. Oakley-Girvans, P. J. Banks, and S. Chang Family History, Perceived Risk, and Prostate Cancer Screening among African American Men. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2167 - 2173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Boers, M P A Zeegers, G M Swaen, I. Kant, and P A van den Brandt The influence of occupational exposure to pesticides, polycyclic aromatic hydrocarbons, diesel exhaust, metal dust, metal fumes, and mineral oil on prostate cancer: a prospective cohort study Occup. Environ. Med., August 1, 2005; 62(8): 531 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Schaid The complex genetic epidemiology of prostate cancer Hum. Mol. Genet., April 1, 2004; 13(90001): R103 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Stanford, L. P. Sabacan, E. A. Noonan, L. Iwasaki, J. Shu, Z. Feng, and E. A. Ostrander Association of HPC2/ELAC2 Polymorphisms with Risk of Prostate Cancer in a Population-based Study Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 876 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Nelson, A. M. De Marzo, and W. B. Isaacs Prostate Cancer N. Engl. J. Med., July 24, 2003; 349(4): 366 - 381. [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. R. Alavanja, C. Samanic, M. Dosemeci, J. Lubin, R. Tarone, C. F. Lynch, C. Knott, K. Thomas, J. A. Hoppin, J. Barker, et al. Use of Agricultural Pesticides and Prostate Cancer Risk in the Agricultural Health Study Cohort Am. J. Epidemiol., May 1, 2003; 157(9): 800 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. El-Bayoumy, J. P. Richie Jr., T. Boyiri, D. Komninou, B. Prokopczyk, N. Trushin, W. Kleinman, J. Cox, B. Pittman, and S. Colosimo Influence of Selenium-enriched Yeast Supplementation on Biomarkers of Oxidative Damage and Hormone Status in Healthy Adult Males: A Clinical Pilot Study Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1459 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wang, S. K. McDonnell, D. A. Elkins, S. L. Slager, E. Christensen, A. F. Marks, J. M. Cunningham, B. J. Peterson, S. J. Jacobsen, J. R. Cerhan, et al. Role of HPC2/ELAC2 in Hereditary Prostate Cancer Cancer Res., September 1, 2001; 61(17): 6494 - 6499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Goode, J. L. Stanford, M. A. Peters, M. Janer, M. Gibbs, S. Kolb, M. D. Badzioch, L. Hood, E. A. Ostrander, and G. P. Jarvik Clinical Characteristics of Prostate Cancer in an Analysis of Linkage to Four Putative Susceptibility Loci Clin. Cancer Res., September 1, 2001; 7(9): 2739 - 2749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Myers, T. Hyslop, K. Jennings-Dozier, T. A. Wolf, D. Y. Burgh, J. A. Diehl, C. Lerman, and G. W. Chodak Intention to Be Tested for Prostate Cancer Risk among African-American Men Cancer Epidemiol. Biomarkers Prev., December 1, 2000; 9(12): 1323 - 1328. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. P. Jarvik, J. L. Stanford, E. L. Goode, R. McIndoe, S. Kolb, M. Gibbs, L. Hood, and E. A. Ostrander Confirmation of Prostate Cancer Susceptibility Genes Using High-Risk Families J Natl Cancer Inst Monographs, December 1, 1999; 1999(26): 81 - 87. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Mukherjee, A. V. Sotnikov, H. J. Mangian, J.-R. Zhou, W. J. Visek, and S. K. Clinton Energy Intake and Prostate Tumor Growth, Angiogenesis, and Vascular Endothelial Growth Factor Expression J Natl Cancer Inst, March 17, 1999; 91(6): 512 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Cerhan, A. S. Parker, S. D. Putnam, B. C-H. Chiu, C. F. Lynch, M. B. Cohen, J. C. Torner, and K. P. Cantor Family History and Prostate Cancer Risk in a Population-Based Cohort of Iowa Men Cancer Epidemiol. Biomarkers Prev., January 1, 1999; 8(1): 53 - 60. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. Giovannucci, M. J. Stampfer, K. Krithivas, M. Brown, A. Brufsky, J. Talcott, C. H. Hennekens, and P. W. Kantoff The CAG repeat within the androgen receptor gene and its relationship to prostate cancer PNAS, April 1, 1997; 94(7): 3320 - 3323. [Abstract] [Full Text] [PDF]
|
|